News and Press Releases
PMGroup Worldwide Ltd, a wholly owned subsidiary of Datateam Business Media Ltd, adds Laboratory News to publications portfolio
24 February 2026 -- London, UK -- PMGroup Worldwide Ltd are pleased to announce the acquisition of Laboratory News magazine and website, together with Laboratory Talk website, from Synthesis Media. Laboratory News has for...
Category: BioManufacturing, Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 24, 2026
Mansard House, Church Road, Little Bookham, Leatherhead, Surrey, KT23 3JG
Cold Chain Technologies opens major Mumbai facility
Cold Chain Technologies (CCT) has officially opened a new 42,000-square-foot, state-of-the-art facility in Taloja, Navi Mumbai, further expanding its presence in India. The site, which integrates CCTs global portfolio with...
Category:
Posted: February 24, 2026
Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California
24 February 2026 -- California, US -- Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand opening of its new Early Phase Center of Excellence, a state of...
Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: February 24, 2026
Etihad Cargo Delivers Strong 2025 Performance with 9% Volume Growth and 8% Revenue Increase
Abu Dhabi, U.A.E. - 24 February 2026: Etihad Cargo, the logistics arm of Etihad Airways, delivered strong performance in 2025, increasing revenue by 8% year-on-year while transporting 703,000 leg tonnes,...
Category:
Posted: February 24, 2026
NICE Recommends TEPKINLY▼ (epcoritamab), a Subcutaneous Bispecific Antibody for Adults With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) After Two or More Lines of Systemic Therapy
Epcoritamab can now be accessed as an option to treat relapsed or refractory follicular lymphoma in adults after 2 or more lines of systemic treatment, only if epcoritamab is stopped...
Category: Drug Discovery, Other, Pharmaceutical
Posted: February 23, 2026
Primera Selects Cenevo’s Labguru to Transition from Paper to Digitalised Workflow
London & Princeton, New Jersey – February 18, 2026 – Primera Analytical Solutions (Primera), an FDA-compliant analytical Contract Research Organization (CRO), has selected Cenevo’s Labguru electronic lab notebook (ELN) and inventory management platform to streamline its...
Category:
Posted: February 19, 2026
Cold Chain Technologies boosts its commitment to Cell & Gene Therapies by partnering with Gobi Technologies
Cold Chain Technologies (CCT) has announced a strategic partnership with Gobi Technologies to give customers access to a greater range of temperature-controlled containers for Cell and Gene Therapies. The deal...
Category:
Posted: February 19, 2026
Proveris Laboratories Launches Redesigned Website Focused on Analytical Clarity in OINDP Development
Hudson, MA, February 18, 2026 — Proveris Laboratories announced the launch of a redesigned website centered on its analytical and regulatory expertise in orally inhaled and nasal drug product (OINDP)...
Category:
Posted: February 19, 2026
Emmes Coordinates Groundbreaking Stem-Cell Ophthalmology Trial
18 February 2026 -- Maryland, US -- Emmes, a full-service, global Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation – in collaboration with the UC Davis Eye...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 18, 2026
Oncoinvent to Present Positive 24-month Follow-up Data from Phase 1 Ovarian Cancer Study of Radspherin at ESGO 2026
9 of 10 patients at the highest dose remained free from peritoneal recurrence at 24 months at the recommended dose 17 February 2026 -- Oslo, Norway -- Oncoinvent, a biotech...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 17, 2026
FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference
Presentation will highlight lead clinical candidate FMP374, a novel dual-acting NMDAR modulator advancing toward IND-enabling studies for TRD 17 February 2026 -- Heidelberg, Germany -- FundaMental Pharma GmbH, a preclinical-stage...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: February 17, 2026
Lytix Biopharma Publishes Comprehensive Review on the Transformative Potential of Oncolytic Peptides in Leading Cancer Journal (JITC)
17 February 2026 -- Oslo, Norway -- Lytix Biopharma AS, a clinical-stage immuno-oncology company, today announced the publication of a review article in the Journal of ImmunoTherapy of Cancer (JITC)....
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: February 17, 2026
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
European Commission grants approval for Gotenfia, a golimumab biosimilar to Simponi that was developed by Bio-Thera and will be marketed by STADA Launch preparations are underway to bring the second...
Category: BioManufacturing, Drug Discovery, Manufacturing and Packing, Other, Pharmaceutical
Posted: February 13, 2026
Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant
11 February 2026 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 11, 2026
Neogap secures SEK 87 million to advance clinical development of its personalised immunotherapy
11 February 2026 -- Solna, Sweden -- Neogap Therapeutics AB, a Swedish biotechnology company developing personalised immunotherapy for cancer treatment, has raised SEK 87 million in a financing round led...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 11, 2026
Stiftelsen Cancercentrum Karolinska (CCK) Visionsgatan 56 171 64 Solna, Sweden
